HomeATAI • NASDAQ
add
ATAI Life Sciences NV
Previous close
$1.63
Day range
$1.59 - $1.65
Year range
$1.02 - $2.85
Market cap
269.52M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.08M | -19.85% |
Net income | -26.71M | 19.38% |
Net profit margin | — | — |
Earnings per share | -0.17 | 19.05% |
EBITDA | -24.01M | 19.85% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 106.25M | -57.48% |
Total assets | 269.12M | -4.13% |
Total liabilities | 45.86M | 14.44% |
Total equity | 223.26M | — |
Shares outstanding | 158.89M | — |
Price to book | 1.16 | — |
Return on assets | -21.40% | — |
Return on capital | -23.62% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -26.71M | 19.38% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2018
Website
Employees
83